IMARC Group's report titled "Cell Dissociation Market Report by Product (Enzymatic Dissociation, Non-Enzymatic Dissociation, Instruments and Accessories), Type (Tissue Dissociation, Cell Detachment), End Use (Pharmaceutical and Biotechnology Companies, Research and Academic Institutes), and Region 2024-2032" The global cell dissociation market size reached US$ 359.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,052.8 Million by 2032, exhibiting a growth rate (CAGR) of 12.69% during 2024-2032.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/cell-dissociation-market/requestsample
Factors Affecting the Growth of the Cell Dissociation Industry:
- Rising Demand for Biopharmaceuticals:
Biopharmaceuticals, including monoclonal antibodies, vaccines, and cell therapies, require large-scale production of biologically active molecules. This production often starts with the dissociation of cells from tissues to obtain a high yield of viable cells for further processing and cultivation. The manufacturing of biopharmaceuticals involves extensive cell culture processes. Efficient and gentle dissociation methods are essential to harvest cells without compromising their viability and functionality, which is crucial for producing high-quality biopharmaceutical products.
- Technological Advancements:
Innovations are leading to the development of more efficient cell dissociation methods. These methods often result in higher yields of viable cells from tissues, improving overall productivity in research, bioprocessing, and clinical applications. Advanced technologies enable gentler dissociation processes, preserving the viability and functionality of isolated cells. This is particularly important for applications requiring intact cellular structures and physiological functions, such as cell therapy and tissue engineering.
- Increasing Focus on Cell-Based Assays:
Cell-based assays rely on cultured cells as model systems for studying various biological processes, drug responses, and disease mechanisms. Efficient cell dissociation methods are essential for harvesting cells from tissues or culture vessels to initiate or replenish cell cultures for these assays. Primary cells, derived directly from tissues or organs, are often preferred for cell-based assays due to their physiological relevance and functional characteristics. Cell dissociation techniques are necessary to isolate primary cells from tissues while maintaining their viability and functionality for downstream experimentation.
Leading Companies Operating in the Global Cell Dissociation Industry:
- Becton Dickinson and Company
- Capricorn Scientific GmbH
- Cytiva (Danaher Corporation)
- F. Hoffmann-La Roche Ltd.
- HiMedia Laboratories Pvt. Ltd.
- Miltenyi Biotec
- PAN-Biotech GmbH
- Sartorius AG
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.
- Vitacyte LLC
Cell Dissociation Market Report Segmentation:
By Product:
- Enzymatic Dissociation
- Trypsin
- Collagenase
- Elastase
- Papain
- Hyaluronidase
- DNase
- Others
- Non-Enzymatic Dissociation
- Instruments and Accessories
Enzymatic dissociation represents the largest segment as it is effective in preserving cell viability and functionality.
By Type:
- Tissue Dissociation
- Cell Detachment
Tissue dissociation holds the biggest market share due to the rising focus on regenerative medicine, stem cell research, and tissue engineering.
By End Use:
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutes
Pharmaceutical and biotechnology companies account for the largest market share on account of the increasing need to maintain product quality and adhere to strict regulatory standards.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America enjoys the leading position in the cell dissociation market, which can be attributed to the presence of advanced research infrastructure.
Global Cell Dissociation Market Trends:
The growing demand for biopharmaceuticals is driving the need for efficient cell dissociation techniques to support upstream processing and production of monoclonal antibodies, vaccines, and cell-based therapies. Rising interest in stem cell research and regenerative medicine is catalyzing the demand for reliable dissociation methods for isolating and culturing stem cells from various sources, including embryonic, adult, and induced pluripotent stem cells.
Focus on personalized medicine is driving the use of patient-derived cells for disease modeling, drug screening, and treatment optimization, increasing the demand for cell dissociation products tailored as per individual patient profiles.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163